Search results for "biopharm" in Articles / App Notes
Article
Brazil Emerges as Global Biopharm Collaborator
According to industry associations, biopharmaceutical innovation in Brazil will increase in the future as the country starts facing its challenges and participating globally with local and multination…
Article
Report: Branded Biopharms Most Exposed to Biosimilar Competition
In a new report on the global biosimilar drugs market, Biosimilars: Parsing the Industry's Pipelines, Moody's Investors Service reports that while biosimilar products have been launched in Asia and …
Article
KUBio modular biopharm facility built in Germany, assembled in China
Cytiva is supplying a full biopharmaceutical processing solution, known as a KUBio, to JHL Biotech in Wuhan, China. The sixty-two completed modules that make up the factory have completed the journe…
Article
Q&As with Industry Leaders
Jeanne Linke Northrop, BioPharm International
Nora Ketterer, Manager, Modeling Services, Cytiva
Top Tips for Successful Development of Antibody Chromatography Processes
Jeanne L…
Article
Challenges and Trends in Biopharma Facility Design
Sep 1, 2014
By: Susan Haigney
BioPharm International
Volume 27, Issue 9, pp. 26-30
Facility design is an important aspect of biopharmaceutical manufacturing. “Global deployment, cost…
Article
A Look Ahead at BioPharma Manufacturing and Regulation
BioPharm International spoke to FDA about these issues in a special interview on the future of bio/pharmaceutical regulation.
DRUG-MANUFACTURING QUALITY
BioPharm: In August 2011, F…
Article
Biopharma Advances Demand Specialized Expertise
The approval of the first biosimilar in the United States, as well as continuing consolidation in the biopharma and contract development and manufacturing markets, are just two indicators of the ongoi…
Article
Best Practices for Data Integrity
By Jennifer Markarian
Maintaining data integrity is essential for all biopharmaceutical manufacturing operations. BioPharm International interviewed Dan Nelson, Customer Expe…
Article
Being Thorough When Transferring Technology
By Susan Haigney
Editor's note: The following is an extended version of the article published in the print version of BioPharm International's March 2017 issue:
Tech transfer and scale up of b…
Article
Risk Assessment and Mitigation in Biopharmaceutical Manufacturing
Jul 01, 2015
By Susan Haigney
BioPharm International
Volume 28, Issue 7, pg 34–36
BioPharm International spoke with Stephan Krause, director of quality assurance, Laura Jeannel, asso…